Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

Heart Valves

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...

Mitral Regurgitation III: Medical Management

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...

Mitral Valve Prolapse II: Assessment and Management

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Piezoelectric materials for tissue engineering and regenerative medicine: From fundamental principles to clinical applications.

Acta biomaterialia·2026

Same author

In silico analysis of the haemodynamic disturbances caused by the subaortic membrane pathology.

Computers in biology and medicine·2026

Same author

The use of human decellularized amniotic membrane as pulmonary valve leaflets in right ventricular outflow tract reconstruction - an <i>in vivo</i> proof of concept study.

Frontiers in bioengineering and biotechnology·2026

Same author

Retraction of "3D Protein-Based Bilayer Artificial Skin for the Guided Scarless Healing of Third-Degree Burn Wounds in Vivo".

Biomacromolecules·2026

Same author

Author Correction: Valvulogenesis of a living, innervated pulmonary root induced by an acellular scaffold.

Communications biology·2025

Same author

Functionalization of graphene oxide and its applications in tissue engineering and regenerative medicine.

Biomaterials advances·2025

Same journal

Biomechanical Performance of Zirconia-Calcium Silicate-Silver Hybrid Dental Crown Under Static and Transient Dynamic Loading: A Finite Element and TOPSIS-Based Multi-Criteria Evaluation.

Journal of biomedical materials research. Part B, Applied biomaterials·2026

Same journal

Synthesis, Characterization, and Implantation of Ferulic Acid-Loaded Chitosan/Aloe vera Hydrogels in Rat Full-Thickness Wound Model.

Journal of biomedical materials research. Part B, Applied biomaterials·2026

Same journal

Double-Crosslinked SIS-Derived Collagen/Alginate Hydrogel With Antibacterial and Pro-Regenerative Activities for Soft Tissue Repair.

Journal of biomedical materials research. Part B, Applied biomaterials·2026

Same journal

Silver and Gold Nanoparticles Promote Antimicrobial Activity and Modulate Inflammation in Escherichia coli-Infected Wounds.

Journal of biomedical materials research. Part B, Applied biomaterials·2026

Same journal

Injectable Thermosensitive Placental ECM-Copper Hydrogel With Endothelial Progenitor Cells for Pressure Ulcer Repair.

Journal of biomedical materials research. Part B, Applied biomaterials·2026

Same journal

Strut Thickness and Species-Specific Healing Are Key Considerations in Developing Zinc-Based Biodegradable Arterial Stents.

Journal of biomedical materials research. Part B, Applied biomaterials·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Published on: October 17, 2013

Current developments and future prospects for heart valve replacement therapy.

Asmeret G Kidane¹, Gaetano Burriesci, Patricia Cornejo

¹Biomaterial and Tissue Engineering Centre (BTEC), Academic Division of Surgery & Interventional Sciences, University College London, London, United Kingdom.

Journal of Biomedical Materials Research. Part B, Applied Biomaterials

|July 11, 2008

Summary

This summary is machine-generated.

New heart valve replacements using advanced polymers and tissue engineering aim to overcome limitations of current prostheses. These innovations offer improved durability and reduced risks, potentially avoiding open-heart surgery for valve disease patients.

More Related Videos

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

Related Experiment Videos

Last Updated: Jul 3, 2026

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Published on: October 17, 2013

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

Area of Science:

Biomaterials Science
Cardiovascular Surgery
Regenerative Medicine

Background:

Current mechanical and bio-prosthetic heart valves have limitations including thrombosis, poor durability, and lack of growth, necessitating re-operations.
Traditional valve replacement requires risky open-heart surgery, posing challenges for pediatric and elderly patients.
Existing prosthetic heart valves are imperfect, leading to ongoing patient risks and complications.

Purpose of the Study:

To review the current state of prosthetic heart valve technology and its clinical applications.
To explore advancements in polymeric materials, tissue engineering, and percutaneous valve replacement.
To discuss future prospects for improved heart valve replacement therapies.

Main Methods:

Review of recent literature on polymeric materials for prosthetic heart valves.
Analysis of tissue engineering approaches for heart valve regeneration.
Examination of developments in percutaneous valve replacement technologies.

Main Results:

Polymeric materials are being developed to address clinical issues with mechanical and bio-prosthetic valves.
Tissue engineering offers potential for creating living, growing heart valves.
Percutaneous valve replacement technologies are advancing, providing less invasive options.

Conclusions:

Novel approaches in polymer science and tissue engineering show promise for next-generation heart valves.
Percutaneous technologies are expanding treatment options for valvular heart disease.
Future heart valve replacement therapies aim for improved durability, reduced invasiveness, and better patient outcomes.